Nine Masts Capital’s Pulmonx LUNG Stock Holding History

Nine Masts Capital’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-38,598	Closed	-$49.8K	–	246
2026 Q1	$49.8K	Buy	38,598 +28,492	+282%	+$47.1K	0.01%	139
2025 Q4	$22.3K	Buy	+10,106	New	+$19K	﹤0.01%	100

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Nine Masts Capital's LUNG Position: Q2 2026 in Review

Nine Masts Capital sold out of Pulmonx (LUNG) in Q2 2026, closing a stake of 38,598 shares — an estimated $49.8K sold.

Nine Masts Capital first reported a position in LUNG in Q4 2025 and held it in 2 quarters. The position peaked at $49.8K in Q1 2026. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

Nine Masts Capital reported no remaining Pulmonx position as of Q2 2026 after selling out during the quarter.
Nine Masts Capital sold 38,598 Pulmonx shares in Q2 2026, an estimated $49.8K.
Nine Masts Capital first reported a position in Pulmonx in Q4 2025 and held it in 2 quarters.
Nine Masts Capital's Pulmonx position peaked at $49.8K in Q1 2026.
108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.